珠江鋼琴(002678.SZ):廣州產投完成受讓16.40%股份 位列第二大股東
格隆匯5月19日丨珠江鋼琴(002678.SZ)公佈,公司於今日收到廣州產投轉發的中國證券登記結算有限責任公司出具的《證券過户登記確認書》,廣州市國資委已將其持有的公司無限售流通股約2.23億股(佔公司總股本的16.40%)轉讓給廣州產投,於2022年5月18日完成過户登記手續,股份性質為無限售流通股。
該次國有股權協議轉讓事項完成後,公司實際控制人不會發生變更,仍為廣州市國資委,廣州市國資委不再直接持有公司股份;廣州產投直接持有公司股份數量約為2.23億股,佔公司總股本的16.40%,為公司第二大股東。該次國有股權協議轉讓不會對公司的正常生產經營產生影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.